[1] ZORIO V,VENET F,DELWARDE B,et al.Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge[J].Ann Intensive Care,2017,7(1):80-82.
[2] 黄怡玲,郑可鲁.应激性高血糖对脓毒血症儿童免疫功能和预后的影响[J].现代医学,2016,44(3):288-291.
[3] VIJAYAN A L,VANIMAY A,RAVINDRAN S,et al.Procalcitonin:a promising diagnostic marker for sepsis and antibiotic therapy[J].J Intensive Care,2017,5:51-53.
[4] TRASY D,MOLNAR Z.Procalcitonin-assisted antibiotic strategy in sepsis[J]. EJIFCC,2017, 28(2):104-113.
[5] LJUNGSTROM L,PERNESTIG A K,JACOBSSON G,et al.Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis[J].PLoS One,2017,12(7):e181704.
[6] 王聪敏,刘锦明,招建玲.N末端前体脑钠肽(NT-proBNP)在急诊脓毒血症预后判断中的应用[J].中国医药指南,2013(14):195-196.
[7] 高戈,冯喆,常志刚,等.2012国际严重脓毒症及脓毒性休克诊疗指南[J].中华危重病急救医学,2013,25(8):501-505.
[8] MUNGHATE A,KUMAR A,MITTAL S,et al.Acute physiological and chronic health evaluation Ⅱ score and its correlation with three surgical strategies for management of ileal perforations[J].J Surg Tech Case Rep,2015,7(2):32-36.
[9] RHEE C.Using procalcitonin to guide antibiotic therapy[J].Open Forum Infect Dis, 2017,4(1):w249-251.
[10] ZHAO R,DONG S.Clinical value of serum endocan and procalcitonin in early diagnosis and prognosis evaluation of sepsis[J].Emergency Medicine for Critical Illness in China,2017,29(4):321-326.
[11] 裴华,胡浩荣,谭华侨,等.PCT、LAC/ScvO_2对脓毒血症患者病情与预后的评估价值[J].现代医学,2016,44(10):1419-1422.
[12] 苗强,李立新,唐江涛,等.脓毒血症患者高敏肌钙蛋白T水平及预后判断的价值研究[J].中国实验诊断学,2017,21(3):438-441. |